Organization
Entasis Therapeutics
1 clinical trial
Clinical trial
A Randomized, Active-controlled Study to Evaluate the Efficacy and Safety of Intravenous Sulbactam-ETX2514 in the Treatment of Patients With Infections Caused by Acinetobacter Baumannii-calcoaceticus ComplexStatus: Completed, Estimated PCD: 2021-07-26